Mitochondria‐targeted antioxidant (MitoQ) ameliorates age‐related arterial endothelial dysfunction in mice

RA Gioscia‐Ryan, TJ LaRocca… - The Journal of …, 2014 - Wiley Online Library
Key points The development of age‐related arterial endothelial dysfunction, a key
antecedent of increased cardiovascular disease (CVD) risk, is mediated largely by reduced …

[HTML][HTML] Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice

RA Gioscia-Ryan, TJ LaRocca, AL Sindler… - The Journal of …, 2014 - ncbi.nlm.nih.gov
Age-related arterial endothelial dysfunction, a key antecedent of the development of
cardiovascular disease (CVD), is largely caused by a reduction in nitric oxide (NO) …

[引用][C] Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice

RA Gioscia-Ryan, TJ LaRocca, AL Sindler… - The Journal of …, 2014 - cir.nii.ac.jp
Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial
dysfunction in mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.

RA Gioscia-Ryan, TJ LaRocca, AL Sindler… - The Journal of …, 2014 - europepmc.org
Age-related arterial endothelial dysfunction, a key antecedent of the development of
cardiovascular disease (CVD), is largely caused by a reduction in nitric oxide (NO) …

Mitochondria‐targeted antioxidant (MitoQ) ameliorates age‐related arterial endothelial dysfunction in mice

RA Gioscia‐Ryan, TJ LaRocca, AL Sindler… - The Journal of …, 2014 - infona.pl
Key points The development of age‐related arterial endothelial dysfunction, a key
antecedent of increased cardiovascular disease (CVD) risk, is mediated largely by reduced …

Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice

RA Gioscia-Ryan, TJ LaRocca… - The Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Age-related arterial endothelial dysfunction, a key antecedent of the development of
cardiovascular disease (CVD), is largely caused by a reduction in nitric oxide (NO) …